ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TVTX Travere Therapeutics Inc

7.71
0.04 (0.52%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Travere Therapeutics Inc TVTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.52% 7.71 20:00:00
Open Price Low Price High Price Close Price Prev Close
7.74 7.41 7.98 7.71 7.67
more quote information »

Recent News

Date Time Source Heading
3/13/202417:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
3/11/202407:05GLOBETravere Therapeutics Submits Supplemental New Drug..
2/26/202416:30GLOBETravere Therapeutics to Present at Upcoming Investor..
2/23/202416:05EDGAR2Form 8-K - Current report
2/23/202407:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
2/23/202402:00PRNCACSL Vifor and Travere Therapeutics announce sparsentan..
2/20/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202416:05EDGAR2Form 8-K - Current report
2/15/202416:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
2/14/202414:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202416:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
2/02/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202421:58EDGAR2Form 144 - Report of proposed sale of securities
2/01/202421:58EDGAR2Form 144 - Report of proposed sale of securities
2/01/202421:57EDGAR2Form 144 - Report of proposed sale of securities
2/01/202416:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
2/01/202412:44EDGAR2Form 144 - Report of proposed sale of securities
2/01/202409:52EDGAR2Form 144 - Report of proposed sale of securities
1/25/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:05GLOBETravere Therapeutics Announces Licensing Agreement with..
1/23/202413:17EDGAR2Form 144 - Report of proposed sale of securities
1/23/202410:51EDGAR2Form 144 - Report of proposed sale of securities
1/08/202407:07EDGAR2Form 8-K - Current report
1/08/202407:00GLOBETravere Therapeutics Provides Corporate Update and 2024..
1/05/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:30GLOBETravere Therapeutics to Present at the 42nd Annual J.P...
12/14/202307:30GLOBETravere Therapeutics Initiates Pivotal Phase 3 Clinical..
12/04/202317:14DJNTravere Shares Rise 8.4%; Co. To Cut Staff, Focus on IgAN,..
12/04/202316:10EDGAR2Form 8-K - Current report
12/04/202316:05GLOBETravere Completes Successful pre-NDA Meeting for FILSPARI in..
11/21/202316:30GLOBETravere Therapeutics to Present at the 6th Annual Evercore..
11/07/202317:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202316:04EDGAR2Form 8-K - Current report
11/07/202316:01GLOBETravere Therapeutics Reports Third Quarter 2023 Financial..
11/03/202310:46GLOBETravere Therapeutics Announces Late-Breaking Data from Phase..
10/24/202316:30GLOBETravere Therapeutics to Report Third Quarter 2023 Financial..
10/13/202316:30GLOBETravere Therapeutics to Present Abstracts at the American..
10/11/202317:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
10/04/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/26/202316:30GLOBETravere Therapeutics to Present Abstracts at the 17th..
9/21/202307:35EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock